Docs overprescribe branded drugs: UK report

Share this article:
The UK government says British doctors are overprescribing branded drugs and that pharma marketers are to blame.

One-fifth of general practitioners surveyed said their prescribing behavior was more influenced by pharma marketing than advice from the nation's National Health Service (NHS), according to a Committee of Public Accounts (CPA) study.

The CPA says NHS spends at least $395 million more than it should because UK physicians prescribe higher-cost branded medications rather than cheaper generic versions to their patients.
 “It's hard to doubt that the blandishments of the pharmaceutical industry are having an effect,” said Edward Leigh, chairman of the CPA in a published report.

Meanwhile, a separate report from British Parliament concluded that the NHS doesn't adopt new, branded medications at a quick enough pace.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...